Journal of medicinal and pharmaceutical chemistry 2013-04-11

Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.

Yi Zhang, Amgad Albohy, Yao Zou, Victoria Smutova, Alexey V Pshezhetsky, Christopher W Cairo

Index: J. Med. Chem. 56(7) , 2948-58, (2013)

Full Text: HTML

Abstract

In the past two decades, human neuraminidases (human sialidases, hNEUs) have been found to be involved in numerous pathways in biology. The development of selective and potent inhibitors of these enzymes will provide critical tools for glycobiology, help to avoid undesired side effects of antivirals, and may reveal new small-molecule therapeutic targets for human cancers. However, because of the high active site homology of the hNEU isoenzymes, little progress in the design and synthesis of selective inhibitors has been realized. Guided by our previous studies of human NEU3 inhibitors, we designed a series of C4,C7-modified analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) and tested them against the full panel of hNEU isoenzymes (NEU1, NEU2, NEU3, NEU4). We identified inhibitors with up to 38-fold selectivity for NEU3 and 12-fold selectivity for NEU2 over all other isoenzymes. We also identified compounds that targeted NEU2 and NEU3 with similar potency.


Related Compounds

Related Articles:

Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.

2013-01-01

[Influenza Other Respi. Viruses 7 Suppl 1 , 14-24, (2013)]

Genetic ancestor of external antigens of pandemic influenza A/H1N1 virus.

2012-12-01

[Interdiscip. Sci. 4(4) , 282-90, (2012)]

Nucleic acid-based detection of influenza A virus subtypes H7 and N9 with a special emphasis on the avian H7N9 virus.

2014-01-01

[Euro Surveill. 19(10) , (2014)]

Department of Health's misguided alert recommending neuraminidase inhibitors for flu.

2014-01-01

[BMJ 348 , g1594, (2014)]

A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.

2014-01-01

[Euro Surveill. 19(1) , (2014)]

More Articles...